XERS Xeris Biopharma Holdings, Inc.
$10.73▲ +2.70%
Healthcare
Other
Volume 630.3K
Avg Volume (10D) 2.27M
Key Metrics & Fundamentals
Market Cap
$1.96B
P/E Ratio
122.7
Div Yield
0.00%
52W Range
5.25 - 11.42
% vs 50 MA
13.69%
% vs 200 MA
40.17%
RSI-14
57.3
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.85
Free Cash Flow
$8.05M
Gross Rev
$92.10M
Gross Profit
$79.59M
EBITDA
$9.84M
COGS
$12.51M
Operating Exp
$74.42M
Operating Income
$5.17M
EBIT
$5.17M
Pretax Income
-$31.10M
Net Income
-$31.10M
EPS (Diluted)
-0.18
Price & Volume History
Loading chart…
Recent News
Can Corcept Therapeutics Stock Rally 40% After This Dip?
Trefis · Oct 26, 2026 3:11 AM ET
Xeris Biopharma to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
Business Wire · Oct 22, 2026 8:00 AM ET
Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings
Business Wire · Oct 15, 2026 8:00 AM ET
Why Xeris Biopharma Holdings (XERS) Is Up 5.8% After Raising 2026 Revenue Guidance And Retiring Debt
Simply Wall St. · Oct 8, 2026 3:15 PM ET
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Business Wire · Oct 2, 2026 5:00 PM ET
Update: Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition
MT Newswires · Sep 30, 2026 8:13 AM ET
Xeris Biopharma Holdings Insider Sold Shares Worth $250,000, According to a Recent SEC Filing
MT Newswires · Sep 29, 2026 5:05 PM ET
Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports
Investing.com · Sep 29, 2026 4:17 PM ET
Xeris Biopharma Reportedly Draws Takeover Interest — But Firm Says It’s ‘Not For Sale’
Stocktwits · Sep 29, 2026 2:01 PM ET
Sector Update: Healthcare Stocks Decline Tuesday Afternoon
MT Newswires · Sep 29, 2026 1:40 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See XERS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.